dormakaba Holding AG (0QMS)
London Exchange · UK · prices in GBP · close of 20 Oct 2026
Key indicators
| Last close | GBP 66.20 |
|---|---|
| 52-week range | 47.05 – 71.39 |
| Return, 1 month / 3 months | +7.8% / +19.1% |
| Return, 1 year / 3 years | −3.4% / +49.3% |
| Trend | Uptrend |
| RSI (14) | 60 |
| Volatility (1 year) | 29.6% |
| Worst drawdown (1 year) | -33.7% |
| Average daily value traded | 0.67M GBP |
| Dividend yield | 0.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
dormakaba Holding AG makes and supplies products and services for doors and secure access. Its range includes door closers, locks and cylinders, automatic and sliding door systems, electronic access control, and safe and key management equipment. Customers include building owners, architects, contractors and facility managers in commercial, public and residential settings. The company is based in Switzerland and serves markets around the world through its own operations and partners.
dormakaba Holding AG trades under the code 0QMS on the London Exchange in UK, with its price quoted in pounds sterling (GBP). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
dormakaba Holding AG (0QMS) trades on the London Exchange in UK. It last closed at GBP 66.20 on 20 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 1,411 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 3.4% and over the last three months it rose 19.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 78 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 16.2% | ||
| From 52-week high | -7.3% | ||
| Momentum | 67 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 19.1% | ||
| 6-month return | 25.5% | ||
| 12-month return, skipping the last month | -10.4% | ||
| Stability (higher is calmer) | 52 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 29.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -33.7% | ||
| Liquidity | 49 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.67M GBP | ||
| Zero-volume days | 0.0% | ||
| Income | 23 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.1% | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +1.2% |
|---|---|
| 1 month | +7.8% |
| 3 months | +19.1% |
| 6 months | +25.5% |
| 1 year | −3.4% |
| 3 years | +49.3% |
| 5 years | – |
Signals
| 50-day / 200-day average | 61.92 / 56.98 |
|---|---|
| Golden / death cross (60 days) | Golden, 33 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.60 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 23 Oct 2025 | GBX 0.0920 |
| 14 Oct 2024 | GBX 0.0764 |
| 9 Oct 2023 | GBX 0.0475 |
| 13 Oct 2022 | GBX 0.0575 |
| 14 Oct 2021 | GBX 0.0625 |
| 22 Oct 2020 | GBX 0.0525 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.